Pre‐operative serum CA 125 levels were elevated (> 35U/ml) in 44 of 46 (96%) patients with
epithelial ovarian cancer. Their serum CA 125 levels ranged from 36 to 8670 U/ml and a …

Plasma levels of CA 125 were determined in 113 patients with ovarian cancer of epithelial
origin. Of these, 69 patients had CA 125 measured before the first laparotomy and 84.6% of …

Serum CA 125 levels were obtained from 55 women with epithelial ovarian cancer before a
second-look surgical procedure and serially thereafter. All patients were clinically and …

Preoperative serum CA 125 levels were determined for 36 patients with Stage I and II
ovarian carcinoma. Levels ranged from 9 to 1962 U/ml with a mean of 216 U/ml. In Stage I …

In a prospective study of 52 patients with ovarian malignancy followed up for 3–18 months
the clinical significance of pre‐operative serum CA 125 as a tumour marker was assessed …

The value of CA 125 measurement in the diagnosis and follow–up of ovarian cancer was
studied in 102 patients. The CA 125 levels were elevated in 88%(3221365) of samples from …

Serum CA 125 levels and surgical findings were prospectively compared in 96 secondary
laparotomies performed on patients with epithelial ovarian cancer. All patients had …

Serum CA 125 levels were evaluated in 227 patients with ovarian cancer. CA 125 levels
were elevated in 86% of the patients. All histologic types, including mucinous tumors, were …

Serum CA 125 levels (upper normal value< 35 U/ml) determined before surgery and 3
months after surgery were evaluated as independent prognostic factors for survival in …

Elevated CA 125 level was noted in 0.2-5.9% healthy women, 22-27.8% patients with
benign ovarian cysts, and approximately 80% patients with nonmucinous ovarian cancer. In …